-->

Tag: platinum-based chemotherapy

Home / platinum-based chemotherapy

Categories

Neoadjuvant/adjuvant nivolumab is approved by the USFDA for resectable non-small cell lung cancer

  On October 3, 2024, the Food and Drug Administration sanctioned nivolumab (Opdivo, Bristol Myers Squibb Company) in conjunction with platinum-doublet chemotherapy as neoadjuvant therapy, suc...
platinum-based-chemotherapy

Pembrolizumab with chemotherapy is approved by the USFDA for unresectable advanced or metastatic malignant pleural mesothelioma

  On September 17, 2024, the Food and Drug Administration authorized pembrolizumab (Keytruda, Merck) in conjunction with pemetrexed and platinum-based chemotherapy as the initial treatment for...
platinum-based-chemotherapy

Pembrolizumab is approved by FDA as adjuvant treatment for non-small cell lung cancer

Feb 2023: For stage IB (T2a 4 cm), stage II, or stage IIIA non-small cell lung cancer, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) as adjuvant therapy after resect...
platinum-based-chemotherapy

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

CancerFax is the most trusted online platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies.

Send your medical reports and get a free analysis.

🌟 Join us in the fight against cancer! 🌟

Привет,

CancerFax — это самая надежная онлайн-платформа, призванная предоставить людям, столкнувшимся с раком на поздних стадиях, доступ к революционным клеточным методам лечения.

Отправьте свои медицинские заключения и получите бесплатный анализ.

🌟 Присоединяйтесь к нам в борьбе с раком! 🌟